"In principle, if you can get the NGF into the brain successfully, this could offer a way of slowing down the decline of mental abilities in patients with Alzheimer's disease, " she said.
He says a longevity-gene drug, shielding patients simultaneously from mental deterioration, heart disease and stroke, could be ready in less than a decade.